2026-525360-18-00招募中1 期
A First-in-Human Study of INCA035784 in Participants With Myeloproliferative Neoplasms
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- Incyte Corp.
- 入组人数
- 40
- 试验地点
- 10
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（18-64 Years, 65+ Years）
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
Clinical Trial Information
Scientific
Incyte Corp.
研究点 (10)
Loading locations...
相似试验
招募中
1 期
A Phase 1, Open-Label, Multicenter Study of INCA033890 in Participants with Advanced or Metastatic Solid Tumors2022-502456-31-00Incyte Corp.75
招募中
1 期
A Phase 1, Open-Label, Multicenter Study of INCA036873 in Participants With Advanced Solid Tumors and Hematological MalignanciesHematological malignanciesAdvanced solid tumors2025-523130-11-00Incyte Corp.150
招募中
1 期
A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of INCA033989 Following Subcutaneous or Intravenous Administration in Healthy Adult ParticipantsNCT07448155Incyte Corporation126
招募中
1 期
Study of INCA036978 in Participants With Myeloproliferative NeoplasmsNCT07441694Incyte Corporation218
招募中
1 期
First-in-Human Study of RO78126532025-522101-37-00F. Hoffmann-La Roche AG12